Amsterdam, the Netherlands, 10 July 2014. LSP (Life Sciences Partners), a leading European investor in health care, announces the fourth investment of its Health Economics Fund (LSP HEF) in Rotation Medical, a private US medical device company focused on developing new technologies to treat rotator cuff disease. LSP and existing investor New Enterprise Associates (NEA) co-led the financing, which also included new investor Pappas Ventures and others. The financing round of USD 27.2 million will support the commercial launch and post-market clinical studies of the Rotation Medical rotator cuff system. A link to the Rotation Medical’s press release can be found here.
Contact
Dr. Rudy Dekeyser, Managing Partner LSP HEF
Tel: +31 (0)20 664 55 00